What Is the Minimum Sperm Motility Needed for IVF?

There is no single universal cutoff for sperm motility below which IVF cannot work, because the answer changes dramatically depending on whether conventional IVF or intracytoplasmic sperm injection (ICSI) is used. With conventional IVF, where sperm must swim to and penetrate the egg on their own, motility matters a great deal and fertilization failure rates climb steeply once progressive motility drops below roughly 30 to 40 percent. With ICSI, a single sperm is injected directly into the egg, which means pregnancies have been achieved even with completely immotile sperm. The real clinical question is less about a hard minimum and more about which technique to use, how many motile sperm survive processing, and what additional steps the lab can take when motility is poor.

Why Clinics Focus on Post-Wash Motile Count, Not Raw Motility Percentage

Before eggs and sperm meet in the lab, the semen sample goes through a washing and concentration step that strips away seminal fluid, debris, and dead cells. What matters for predicting success is the number of progressively motile sperm left after that processing, a figure called the total progressive motile sperm count, or TPMSC. A man whose raw sample shows only 20 percent motility might still yield enough motile sperm after washing if his overall count is high. Conversely, a sample with decent motility but very low concentration may wash down to almost nothing useful.

A large study of nearly 7,000 insemination cycles found that pregnancy rates were significantly lower when the post-wash TPMSC fell below about half a million, and the odds of a positive pregnancy result roughly doubled once TPMSC reached at least 5 million.¹ While that study involved intrauterine insemination rather than IVF, the principle carries over: what your clinic cares about is how many healthy, swimming sperm are available in the final prepared sample, not the percentage on the initial semen analysis alone.

For conventional IVF specifically, one study found that a post-wash total motile sperm count below roughly 10 to 11 million should prompt consideration of ICSI instead, because the risk of total fertilization failure rises significantly below that threshold.² This is a practical decision point many fertility clinics use day-of to decide which fertilization method to employ.

Conventional IVF and the Risk of Fertilization Failure

In conventional IVF, thousands of sperm are placed around each egg in a dish, and they have to do the work of reaching and penetrating the egg themselves. This process requires progressive motility, meaning sperm that swim forward in a purposeful direction. When motility is severely compromised, a condition called asthenozoospermia, the odds of total fertilization failure jump substantially.

A controlled comparison between conventional IVF and ICSI in men with asthenozoospermia found the difference was stark. The fertilization rate per egg was about 63 percent with ICSI but only around 23 percent with conventional IVF. Half of the conventional IVF cycles in that study resulted in complete fertilization failure, meaning not a single egg was fertilized.³ The study concluded that when fresh semen shows an absence of, or extremely low proportion of, rapid progressive motility, conventional IVF carries a high risk of complete failure.

An earlier analysis of nearly 600 egg retrieval procedures found that total fertilization failure occurred in about 16 percent of cycles overall, but the rate nearly doubled to around 27 percent when sperm were moderately or severely defective.⁴ These numbers help explain why most clinics now default to ICSI whenever sperm parameters are questionable rather than risk an entire cycle with no embryos to transfer.

How Low Can Motility Go with ICSI?

ICSI changed the landscape for severe male-factor infertility because it bypasses the need for sperm to swim at all. An embryologist selects a single sperm under a microscope, immobilizes it, and injects it directly into the egg. This means the minimum motility needed is, in theory, zero. Pregnancies have been achieved with completely immotile sperm.

That said, outcomes with immotile sperm are worse than with motile sperm. Research has shown that totally immotile ejaculated sperm fertilize significantly fewer eggs after ICSI compared with sperm that showed at least some initial motility.⁵ A comprehensive review noted that immotile sperm (presumably dead) and round-headed sperm were the two conditions with a strongly negative influence on ICSI results.⁶

The central problem with immotile sperm is distinguishing the living from the dead. A sperm that is not moving may be alive but structurally unable to swim, or it may be dead. Injecting a dead sperm into an egg will not produce fertilization. This is why, for men with absolute asthenozoospermia (zero motility), the lab needs additional tools to figure out which sperm are actually viable.

Sorting Live Sperm from Dead Ones When Nothing Is Moving

When an embryologist faces a sample with no motile sperm at all, the standard approach is viability testing. The most widely used method is the hypo-osmotic swelling test, or HOST. Sperm are briefly exposed to a solution with lower salt concentration than normal. A living sperm cell with an intact membrane will swell and its tail will curl, while a dead cell with a damaged membrane will not react. The embryologist can then pick the swollen sperm for injection.

A study using this modified hypo-osmotic approach across 27 treatment cycles in patients with total absence of motility achieved fertilization in about 37 percent of injected eggs, and four pregnancies resulted, giving a pregnancy rate of roughly 15 percent per cycle.⁷ Those numbers are lower than typical ICSI success rates with motile sperm, but they are far from zero. A more recent analysis of over 2,000 eggs injected with either motile or immotile HOST-positive sperm confirmed that HOST is a safe and reasonably reliable method across different sample types, though it performs better on fresh samples than on frozen-thawed ones.⁸

Testicular Sperm as an Alternative When Ejaculated Sperm Are Immotile

In some conditions, sperm are immotile in the ejaculate but may still have some viability or even motility if retrieved directly from the testicle. This is particularly relevant for men with conditions like Kartagener syndrome, where a genetic defect in the cilia prevents sperm tails from functioning normally. Case reports in men with Kartagener syndrome showed that ejaculated immotile sperm led to total fertilization failure in one cycle, while testicular sperm from the same patient achieved 75 percent fertilization and a pregnancy.⁹

More broadly, a comparison of ICSI using testicular sperm versus ejaculated sperm in men with severe male-factor infertility found that fertilization rates were about 42 percent with testicular sperm and about 56 percent with ejaculated sperm.¹⁰ That might seem to favor ejaculated sperm in general, but the picture flips in cases where ejaculated sperm are completely immotile. There, testicular sperm tend to give more predictable results because they have not yet been exposed to the oxidative stress and other damaging conditions of the reproductive tract that may have killed the ejaculated cells. A review of the evidence noted that outcomes vary widely depending on sperm origin and the technique used to select viable immotile sperm.¹¹

Chemical Stimulants That Can Wake Up Sluggish Sperm

Before resorting to viability testing or surgical retrieval, embryology labs sometimes try to chemically stimulate motility in a sluggish sample. Theophylline and pentoxifylline are phosphodiesterase inhibitors that raise levels of a signaling molecule inside the sperm cell, which can kick-start tail movement. These drugs are not given to the patient; they are added to the sperm sample in the lab immediately before the procedure.

In one study of frozen-thawed testicular sperm, theophylline treatment produced a significant motility improvement in nearly 99 percent of patients. The fertilization rate jumped from about 63 percent to roughly 80 percent, blastocyst formation rates rose from about 47 percent to 64 percent, and clinical pregnancy rates more than doubled, going from about 24 percent to 54 percent.¹² A review of the broader literature on both pentoxifylline and theophylline confirmed that artificial sperm activation was associated with higher fertilization rates, better embryo quality, and improved pregnancy rates.¹³

These stimulants serve a dual purpose. They can sometimes restore enough motility to allow the embryologist to pick better sperm for ICSI, and they also function as a quick viability test: a sperm that starts twitching after chemical stimulation is alive, while one that remains inert may be dead. In practice, many labs use pentoxifylline as a first-line approach before turning to HOST.

How Poor Motility Affects the Embryo After Fertilization

Even when fertilization succeeds with low-motility sperm, the resulting embryo may develop differently. Time-lapse imaging of embryo development has shown that sperm with low motility are associated with delays in the earliest cell divisions, particularly the time it takes for pronuclei to fade and for the first cleavage to occur.¹⁴ Another study found that low sperm concentration and motility correlated with lower rates of normal fertilization, fewer good-quality embryos by day 3, and reduced blastocyst formation by day 5 or 6. These effects appeared as early as fertilization itself, with increased fragmentation during the initial cleavages.¹⁵

The reassuring finding, however, is that when pregnancies do occur, the children appear to develop normally. A comparative study of children conceived via ICSI using either testicular sperm or extremely poor ejaculated sperm found that obstetric and perinatal outcomes were similar between groups, and the children were healthy without major developmental issues.¹⁶

When Age Compounds the Problem

Sperm motility does not operate in isolation. The age of both partners, and especially maternal age, interacts with sperm quality in ways that matter for IVF outcomes. One older study established a formula incorporating sperm concentration, motility index, hypo-osmotic swelling test results, and the woman’s age to predict fertilization rates, finding that all four were independently significant predictors. Fertilization rates dropped especially sharply in older women whose partners also had low motility and concentration.¹⁷

More recently, research into embryo aneuploidy (chromosomally abnormal embryos) has shed light on why age and motility together are particularly problematic. In couples where the female partner was 34 or older and the male partner was 40 or older, low sperm motility was associated with higher rates of embryo aneuploidy and lower rates of chromosomally normal embryos compared to men in the same age bracket with higher motility. Interestingly, this effect was not seen in younger couples, suggesting that the combined impact of aging eggs and poor sperm quality creates a compounding effect that neither factor alone produces.¹⁸

Improving Motility Before the Cycle

For men with borderline motility who want to optimize their numbers before an IVF cycle, antioxidant supplementation has the most consistent evidence behind it. A study of IVF patients given antioxidant supplements found a significant reduction in the percentage of immotile sperm cells, with the most dramatic improvements seen in men who started with the worst parameters.¹⁹ A broader evidence review concluded that supplements including L-carnitine, selenium, vitamin C, and vitamin E may improve sperm concentration, motility, morphology, and sometimes DNA integrity.²⁰

The standard lifestyle advice applies as well: avoiding excessive heat exposure, reducing alcohol, stopping smoking, and maintaining a healthy weight all have some evidence behind them for motility improvement. Because sperm take about 74 days to develop, any changes need roughly two to three months to show up in a semen analysis. Starting supplementation three months before a planned IVF cycle gives the best chance of moving the needle on motility.

Newer Lab Techniques for Selecting the Best Sperm

Beyond the standard washing and concentration methods, several newer approaches aim to select higher-quality sperm from a mixed sample. Microfluidic sperm sorting devices use tiny channels that mimic the female reproductive tract, allowing only sperm with strong forward motility and intact DNA to pass through. One study found that microfluidic sorting selected sperm with the highest progressive motility and the lowest DNA fragmentation compared to traditional preparation methods.²¹ There is a catch, though: these devices need a minimum amount of motile sperm in the sample to work. In men with very low counts or very poor motility, traditional density gradient preparation remains the preferred method.²²

Another approach is the PICSI dish, which uses hyaluronan (a molecule found in the layer surrounding the egg) to select sperm that bind to it. The idea is that mature, healthy sperm have receptors for hyaluronan while immature or damaged sperm do not. In ICSI cycles involving male-factor infertility, the PICSI technique was associated with roughly a fivefold higher chance of pregnancy compared to standard morphology-based sperm selection, with the biggest benefit seen in men whose primary issue was poor morphology.²³

It is worth noting that the sperm preparation process itself can cause damage. Standard lab processing methods, including both swim-up and density gradient centrifugation, have been shown to significantly increase levels of reactive oxygen species in sperm compared to the raw semen sample.²⁴ This means some motile sperm that were healthy in the raw sample may be damaged during processing. It is one reason why labs are increasingly interested in gentler sorting methods like microfluidics, and why the raw semen analysis alone does not perfectly predict what the embryologist will have to work with.

The Conventional IVF Versus ICSI Decision

One underappreciated issue in fertility treatment is that ICSI has expanded far beyond its original purpose. It was developed specifically for severe male-factor infertility, but in many clinics worldwide it is now used in the majority of all IVF cycles, including those with normal sperm parameters. A protocol for a large randomized trial noted that ICSI carries unresolved concerns about potential gamete damage, is more labor-intensive, and is more expensive than conventional IVF.²⁵ When motility is genuinely poor, ICSI is clearly the right call. But when motility is borderline, the decision involves weighing the cost of ICSI against the risk of fertilization failure with conventional IVF. Many clinics resolve this tension by converting to ICSI on the day of egg retrieval if the post-wash motile count falls below their threshold, typically somewhere around 5 to 10 million total progressively motile sperm.

Updated WHO reference values for semen analysis, revised in 2021, lowered some thresholds compared to the previous edition. A study comparing outcomes under the older and newer criteria found that men flagged as having worsened parameters under the updated thresholds had significantly more negative outcomes in assisted reproduction, with about 27 percent experiencing poor results versus 49 percent in the group with worse semen quality.²⁶ The evolving reference values are a reminder that “normal” sperm motility is a statistical benchmark derived from fertile men, not a pass-fail line that determines whether IVF can work. Plenty of men with below-reference motility conceive through IVF, and some men with normal numbers still experience fertilization failure. The lab’s ability to adapt its technique to what it sees on the day of retrieval matters as much as any number on a pre-cycle semen report.